Amyotrophic Lateral Sclerosis Genetic Studies: From Genome-wide Association Mapping to Genome Sequencing

Neuroscientist

Volumn 21, Issue 6, 2015, Pages 599-615

  He, Ji ^a,b,c   Mangelsdorf, Marie ^a   Fan, Dongsheng ^b   Bartlett, Perry ^a   Brown, Matthew A ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

Author keywords

amyotrophic lateral sclerosis; epigenetic study; genetic study; genome wide association study; next generation sequencing study

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; COPY NUMBER VARIATION; EPIGENETICS; ETHNIC GROUP; EXOME; EXPECTATION; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; HUMAN; INVESTIGATIVE PROCEDURES; META ANALYSIS (TOPIC); METHYLATION; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; REVIEW; STUDY DESIGN; ANIMAL; ETHNOLOGY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; METHODOLOGY; PROCEDURES; SEQUENCE ANALYSIS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RESEARCH DESIGN; SEQUENCE ANALYSIS;

EID: 84946146369     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858414555404     Document Type: Review

References (105)

1. Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, and others. 2010. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 81 (12): 1324-6.
2. Al-Saif A, Al-Mohanna F, Bohlega S,. 2011. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70 (6): 913-9.
3. Andersen PM, Nilsson P, Keranen ML, Forsgren L, Hagglund J, Karlsborg M, and others. 1997. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 120 (Pt 10): 1723-37.
4. Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, and others. 2013. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A 110 (8): E736-45.
5. Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, and others. 2013. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet 92 (3): 345-53.
6. Birve A, Neuwirth C, Weber M, Marklund SL, Nilsson A-C, Jonsson PA, and others. 2010. A novel SOD1 splice site mutation associated with familial ALS revealed by SOD activity analysis. Hum Mol Genet 19 (21): 4201-6.
7. Blauw HM, Barnes CP, van Vught PW, van Rheenen W, Verheul M, Cuppen E, and others. 2012. SMN1 gene duplications are associated with sporadic ALS. Neurology 78 (11): 776-80.
8. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, and others. 2010. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13 (11): 1396-403.
9. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, and others. 2011. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 82 (6): 623-7.
10. Chen Y, Zeng Y, Huang R, Yang Y, Chen K, Song W, and others. 2012. No association of five candidate genetic variants with amyotrophic lateral sclerosis in a Chinese population. Neurobiol Aging 33 (11): 2721.e3-e5.
11. Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, and others. 2004. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 74 (6): 1128-35.
12. Chesi A, Staahl BT, Jovicic A, Couthouis J, Fasolino M, Raphael AR, and others. 2013. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat Neurosci 16 (7): 851-5.
13. Chio A, Borghero G, Pugliatti M, Ticca A, Calvo A, Moglia C, and others. 2011. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol 68 (5): 594-8.
14. Chio A, Schymick JC, Restagno G, Scholz SW, Lombardo F, Lai SL, and others. 2009. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 18 (8): 1524-32.
15. Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, and others. 2009. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 84 (1): 85-8.
16. Corcia P, Camu W, Halimi JM, Vourc'h P, Antar C, Vedrine S, and others. 2006. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology 67 (7): 1147-50.
17. Corcia P, Mayeux-Portas V, Khoris J, de Toffol B, Autret A, Muh JP, and others. 2002. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol 51 (2): 243-6.
18. Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, and others. 2012. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet 21 (13): 2899-911.
19. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, and others. 2008. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17 (5): 768-74.
20. Cronin S, Hardiman O, Traynor BJ,. 2007. Ethnic variation in the incidence of ALS: a systematic review. Neurology 68 (13): 1002-7.
21. Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O,. 2009. Screening for replication of genome-wide SNP associations in sporadic ALS. Eur J Hum Genet 17 (2): 213-8.
22. Daoud H, Valdmanis PN, Dion PA, Rouleau GA,. 2010. Analysis of DPP6 and FGGY as candidate genes for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11 (4): 389-91.
23. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, and others. 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 (2): 245-56.
24. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G,. 2003. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 60 (5): 813-9.
25. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, and others. 2011. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477 (7363): 211-5.
26. Diekstra FP, Saris CGJ, van Rheenen W, Franke L, Jansen RC, van Es MA, and others. 2012. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One 7 (4): e35333.
27. Diekstra FP, van Vught PWJ, van Rheenen W, Koppers M, Pasterkamp RJ, van Es MA, and others. 2012. UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol Aging 33 (3): 630.e3-e8.
28. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, and others. 2007. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357 (8): 775-88.
29. Elden AC, Kim HJ, Hart Mp, Chen-Plotkin AS, Johnson BS, Fang X, and others. 2010. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466 (7310): 1069-75.
30. Fallis BA, Hardiman O,. 2009. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph Lateral Scler 10 (2): 95-8.
31. Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, and others. 2011. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68 (11): 1440-6.
32. Figueroa-Romero C, Hur J, Bender DE, Delaney CE, Cataldo MD, Smith AL, and others. 2012. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One 7 (12): e52672.
33. Fogh I, D'Alfonso S, Gellera C, Ratti A, Cereda C, Penco S, and others. 2011. No association of DPP6 with amyotrophic lateral sclerosis in an Italian population. Neurobiol Aging 32 (5): 966-7.
34. Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, and others. 2014. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet 23 (8): 2220-31.
35. Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, and others. 2010. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One 5 (7): e11552.
36. Gamez J, Caponnetto C, Ferrera L, Syriani E, Marini V, Morales M, and others. 2011. I112M SOD1 mutation causes ALS with rapid progression and reduced penetrance in four Mediterranean families. Amyotroph Lateral Scler 12 (1): 70-5.
37. Gamez J, Cervera C, Codina A,. 1999. Flail arm syndrome of Vulpian-Bernhart's form of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 67 (2): 258.
38. Garber K,. 2008. Genetics. The elusive ALS genes. Science 319 (5859): 20.
39. Gijselinck I, Engelborghs S, Maes G, Cuijt I, Peeters K, Mattheijssens M, and others. 2010. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 67 (5): 606-16.
40. Gilissen C, Hehir-Kwa JY, Thung DT, van de, Vorst M, van Bon BW, Willemsen MH, and others. 2014. Genome sequencing identifies major causes of severe intellectual disability. Nature 511 (7509): 344-7.
41. Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, and others. 2006. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38 (4): 411-3.
42. Gros-Louis F, Lariviere R, Gowing G, Laurent S, Camu W, Bouchard JP, and others. 2004. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem 279 (44): 45951-6.
43. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, and others. 2001. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29 (2): 166-73.
44. Hardiman O, Greenway M,. 2007. The complex genetics of amyotrophic lateral sclerosis. Lancet Neurol 6 (4): 291-2.
45. Herdewyn S, Zhao H, Moisse M, Race V, Matthijs G, Reumers J, and others. 2012. Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis. Hum Mol Genet 21 (11): 2412-9.
46. Iida A, Takahashi A, Deng M, Zhang Y, Wang J, Atsuta N, and others. 2011a. Replication analysis of SNPs on 9p21.2 and 19p13.3 with amyotrophic lateral sclerosis in East Asians. Neurobiol Aging 32 (4): 757.e13-e14.
47. Iida A, Takahashi A, Kubo M, Saito S, Hosono N, Ohnishi Y, and others. 2011b. A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum Mol Genet 20 (18): 3684-92.
48. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, and others. 2010. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68 (5): 857-64.
49. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, and others. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (7422): 119-24.
50. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, and others. 2013. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495 (7442): 467-73.
51. Kwee LC, Liu Y, Haynes C, Gibson JR, Stone A, Schichman SA, and others. 2012. A high-density genome-wide association screen of sporadic ALS in US veterans. PLoS One 7 (3): e32768.
52. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, and others. 2009. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323 (5918): 1205-8.
53. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, Myllykangas L, and others. 2010. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9 (10): 978-85.
54. Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, and others. 2012. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15 (11): 1488-97.
55. Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, and others. 2009. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 106 (22): 9004-9.
56. Leung CL, He CZ, Kaufmann P, Chin SS, Naini A, Liem RK, and others. 2004. A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol 14 (3): 290-6.
57. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, and others. 2009. Finding the missing heritability of complex diseases. Nature 461 (7265): 747-53.
58. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, and others. 2010. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465 (7295): 223-6.
59. Miller RG, Mitchell JD, Moore DH., 2012. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 3:CD001447.
60. Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, and others. 2010. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci U S A 107 (16): 7556-61.
61. Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, and others. 2012. Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 33 (1): 209.e3-e8.
62. Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, Amininejad L, and others. 2011. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 43 (1): 43-7.
63. Morahan JM, Yu B, Trent RJ, Pamphlett R,. 2009. A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10 (5-6): 418-29.
64. Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, and others. 2006. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66 (6): 839-44.
65. Munch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, and others. 2004. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63 (4): 724-6.
66. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA., 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324 (5925): 387-9.
67. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, and others. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (5796): 130-3
68. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, and others. 2004. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75 (5): 822-31.
69. Norris F, Shepherd R, Denys E, Kwei U, Mukai E, Elias L, and others. 1993. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118 (1): 48-55.
70. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, and others. 2012. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485 (7397): 246-50.
71. Oates N, Pamphlett R,. 2007. An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler 8 (2): 83-6.
72. Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, and others. 2010. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 133 (Pt 2): 591-8.
73. Orru S, Manolakos E, Orru N, Kokotas H, Mascia V, Carcassi C, and others. 2012. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet 81 (2): 172-8.
74. Orsetti V, Pegoraro E, Cima V, D'Ascenzo C, Palmieri A, Querin G, and others. 2011. Genetic variation in KIFAP3 is associated with an upper motor neuron-predominant phenotype in amyotrophic lateral sclerosis. Neurodegener Dis 8 (6): 491-5.
75. Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, and others. 2014. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener 15 (5-6): 453-6.
76. Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, and others. 2006. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67 (6): 1074-7.
77. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, and others. 2011. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14 (4): 459-68.
78. Purcell S, Cherny SS, Sham PC,. 2003. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (1): 149-50.
79. Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, and others. 2012. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33 (10): 2528.e7-e14.
80. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, and others. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72 (2): 257-68.
81. Risch N,. 1987. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 40 (1): 1-14.
82. Risch N,. 1990a. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46 (2): 222-8.
83. Risch N,. 1990b. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46 (2): 229-41.
84. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, and others. 2011. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43 (11): 1066-73.
85. Robberecht W, Aguirre T, Van den Bosch L, Tilkin P, Cassiman JJ, Matthijs G,. 1996. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 47 (5): 1336-9.
86. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, and others. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (6415): 59-62.
87. Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, and others. 2010. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 9 (10): 986-94.
88. Siddique T, Ajroud-Driss S,. 2011. Familial amyotrophic lateral sclerosis, a historical perspective. Acta Myol 30 (2): 117-20.
89. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, and others. 2008. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (5870): 1668-72.
90. Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, and others. 2011. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet 156B (3): 285-90.
91. van Es MA, Dahlberg C, Birve A, Veldink JH, van den Berg LH, Andersen PM,. 2010. Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 81 (5): 562-6.
92. van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, Andersen PM, and others. 2007. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 6 (10): 869-77.
93. van Es MA, van Vught PWJ, Blauw HM, Franke L, Saris CGJ, Van den Bosch L, and others. 2008. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 40 (1): 29-31.
94. van Es MA, Van Vught PWJ, Veldink JH, Andersen PM, Birve A, Lemmens R, and others. 2009a. Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10 (5-6): 441-7.
95. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, and others. 2009b. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41 (10): 1083-7.
96. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, and others. 2006. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 129 (Pt 4): 868-76.
97. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, and others. 2009. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323 (5918): 1208-11.
98. Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, and others. 2005. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 65 (6): 820-5.
99. Wellcome Trust Case Control Consortium, Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, and others. 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464 (7289): 713-20.
100. Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, and others. 2009. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 72 (12): 1087-94.
101. Wu CH, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, and others. 2012. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488 (7412): 499-503.
102. Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, and others. 2013. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet 92 (6): 981-9.
103. Yang Y, Gozen O, Vidensky S, Robinson MB, Rothstein JD,. 2010. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. GLIA 58 (3): 277-86.
104. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, and others. 2001. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 29 (2): 160-5.
105. Zinman L, Liu HN, Sato C, Wakutani Y, Marvelle AF, Moreno D, and others. 2009. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology 72 (13): 1153-9.